Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|July 4, 2009
Synthesis of radiolabeled cytarabine conjugatesPallavi Lagisetty, Prachi Vilekar, Vibhudutta Awasthi
Vaccine|February 24, 2019
Dendritic cell-based immunization induces Coccidioides Ag2/PRA-specific immune responseShanjana Awasthi, Prachi Vilekar, Alexandra Conkleton, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|January 29, 2019
Nutrients in Alzheimer's Disease: The Interaction of Diet, Drugs and DiseaseS Imindu Liyanage, Prachi Vilekar, Donald F Weaver
Journal of Inflammation (London, England)|September 25, 2015
Diphenyldifluoroketone EF24 Suppresses Pro-inflammatory Interleukin-1 receptor 1 and Toll-like Receptor 4 in lipopolysaccharide-stimulated dendritic cellsPrachi Vilekar, Geeta Rao, Shanjana Awasthi, et al.
ACS Chemical Neuroscience|November 23, 2020
Furosemide as a Probe Molecule for the Treatment of Neuroinflammation in Alzheimer's DiseaseZhiyu Wang, Prachi Vilekar, Junbo Huang, et al.
International Immunology|March 2, 2012
EF24 suppresses maturation and inflammatory response in dendritic cellsPrachi Vilekar, Shanjana Awasthi, Aravindan Natarajan, et al.
Bioorganic & Medicinal Chemistry|July 20, 2010
CLEFMA-an anti-proliferative curcuminoid from structure-activity relationship studies on 3,5-bis(benzylidene)-4-piperidonesPallavi Lagisetty, Prachi Vilekar, Kaustuv Sahoo, et al.
Applied Biochemistry and Biotechnology|February 18, 2014
Antibacterial activity of synthetic curcumin derivatives: 3,5-bis(benzylidene)-4-piperidone (EF24) and EF24-dimer linked via diethylenetriaminepentacetic acid (EF2DTPA)Prachi Vilekar, Catherine King, Pallavi Lagisetty, et al.
Pageof 2